Our observation is in line with the recent studies showing that Curcumin, an antioxidant and anti-inflammatory substance derived from the East Indian plant Curcuma longa, inhibits IKKβ activity and suppresses cell proliferation as a single agent or in combination and cisplatin in HNSCC [56–58]. This evidence concerns the gene IKBKB and head and neck squamous cell carcinoma.